Isostearyl Alcohol

Isostearyl Alcohol

SCHEMBL7196856

CC(C)CCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCO

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.65
ALDH1A1 P00352 2/20 0.65
HSD17B10 Q99714 1/20 0.65
MEN1 O00255 1/20 0.65
KMT2A Q03164 1/20 0.65
TSHR P16473 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.60
SPHK1 Q9NYA1 2/20 0.46
OPRM1 P35372 1/20 0.44
CYP2D6 P10635 2/20 0.43
GMNN O75496 1/20 0.43
POLB P06746 1/20 0.43
THPO P40225 1/20 0.43
MTOR P42345 1/20 0.43
BLM P54132 1/20 0.43
KDM4E B2RXH2 1/20 0.43
TP53 P04637 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tridecan-1-Ol SCHEMBL27083604 1.00 LMNA (0.65) LMNAALDH1A1HSD17B10MEN1KMT2A
Hexane SCHEMBL27709517 1.00 LMNA (0.65) LMNAALDH1A1HSD17B10MEN1KMT2A
1-Hexanol SCHEMBL29207083 1.00 LMNA (0.65) LMNAALDH1A1HSD17B10MEN1KMT2A
Dodecane SCHEMBL28250692 1.00 LMNA (0.65) LMNAALDH1A1HSD17B10MEN1KMT2A
1-Hexanol SCHEMBL28135753 1.00 LMNA (0.65) LMNAALDH1A1HSD17B10MEN1KMT2A
Cetyl Alcohol SCHEMBL8909459 1.00 LMNA (0.65) LMNAALDH1A1HSD17B10MEN1KMT2A
Cetostearyl Alcohol SCHEMBL10865247 1.00 LMNA (0.65) LMNAALDH1A1HSD17B10MEN1KMT2A
Dodecanol SCHEMBL27083605 1.00 LMNA (0.65) LMNAALDH1A1HSD17B10MEN1KMT2A
Decane SCHEMBL9796618 1.00 LMNA (0.65) LMNAALDH1A1HSD17B10MEN1KMT2A
Dodecanol SCHEMBL27278430 1.00 LMNA (0.65) LMNAALDH1A1HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1154463-C Persistent hair tonic ������ҩ��ʽ���� 2004-06-23 CN disclosed
US-20030223982-A1 Use of DNA repair enzymes as MMP 1 inhibitors HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 2003-12-04 US disclosed
CN-1244113-A Long-acting hair tonic TAISHO PHARMACEUTICAL CO LTD (JP) 2000-02-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030223982-A1 Use of DNA repair enzymes as MMP 1 inhibitors MMP1, DNASE1, MMP9 LMNA 143/4885ALDH1A1 311/4885HSD17B10 678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.